Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Xiamen Amoytop Biotech Co., Ltd.

Clinical trials sponsored by Xiamen Amoytop Biotech Co., Ltd., explained in plain language.

Trials to join now! 3 Not yet recruiting 2 Completed 1

First step for new fatty liver drug: safety check in healthy volunteers

Knowledge-focused Completed

This was an early-stage safety study for a potential new medicine called ACT500, which is being developed for a serious liver condition called non-alcoholic steatohepatitis (NASH). The study tested single and multiple doses in 72 healthy Chinese adults to see how safe the drug wa…

Phase: PHASE1 • Sponsor: Xiamen Amoytop Biotech Co., Ltd. • Aim: Knowledge-focused

Last updated Mar 30, 2026 14:27 UTC